Literature DB >> 23994646

Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model.

Julie A K McDonald1, Kathleen Schroeter, Susana Fuentes, Ineke Heikamp-Dejong, Cezar M Khursigara, Willem M de Vos, Emma Allen-Vercoe.   

Abstract

In vitro gut models provide several advantages over in vivo models for the study of the human gut microbiota. However, because communities developed in these models are inevitably simplified simulations of the in vivo environment, it is necessary to broadly define the differences between in vitro consortia and the communities from which they are derived. In this study we characterized microbial community development in a twin-vessel single-stage chemostat model of the human distal gut ecosystem using both gel (Denaturing Gradient Gel Electrophoresis) and phylogenetic microarray (Human Intestinal Tract Chip) based techniques. Five different sets of twin-vessels were inoculated with feces from three different healthy adult donors and allowed to reach steady state compositions. We found that twin-vessel single-stage chemostats could develop and maintain stable, diverse, and reproducible communities that reach steady state compositions in all five runs by at most 36 days post-inoculation. As noted in other in vitro studies, steady state communities were enriched in Bacteroidetes but not Clostridium cluster XIVa, Bacilli or other Firmicutes relative to the fecal inocula. Communities developed within this model had higher within-run reproducibility than between-run repeatability when using consecutive fecal donations. Both fecal inocula and steady state chemostat communities seeded with feces from different donors had distinct compositions. We conclude that twin-vessel single-stage chemostat models represent a valid simulation of the human distal gut environment and can support complex, representative microbial communities ideal for experimental manipulation.
© 2013.

Entities:  

Keywords:  Chemostat; DGGE; Human distal gut; Microbial ecology; Microbiota; Phylogenetic microarray

Mesh:

Substances:

Year:  2013        PMID: 23994646     DOI: 10.1016/j.mimet.2013.08.008

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  58 in total

1.  EcoFABs: advancing microbiome science through standardized fabricated ecosystems.

Authors:  Karsten Zengler; Kirsten Hofmockel; Nitin S Baliga; Scott W Behie; Hans C Bernstein; James B Brown; José R Dinneny; Sheri A Floge; Samuel P Forry; Matthias Hess; Scott A Jackson; Christer Jansson; Stephen R Lindemann; Jennifer Pett-Ridge; Costas Maranas; Ophelia S Venturelli; Matthew D Wallenstein; Elizabeth A Shank; Trent R Northen
Journal:  Nat Methods       Date:  2019-07       Impact factor: 28.547

Review 2.  Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.

Authors:  E G Pamer
Journal:  Mucosal Immunol       Date:  2014-01-08       Impact factor: 7.313

Review 3.  Recent Advancements in Intestinal Microbiota Analyses: A Review for Non-Microbiologists.

Authors:  Xiao-Wei Feng; Wen-Ping Ding; Ling-Yun Xiong; Liang Guo; Jia-Ming Sun; Peng Xiao
Journal:  Curr Med Sci       Date:  2018-12-07

4.  Comparative analysis of the gut microbiota cultured in vitro using a single colon versus a 3-stage colon experimental design.

Authors:  Jenni Firrman; LinShu Liu; Karley Mahalak; Ceylan Tanes; Kyle Bittinger; Jamshed Bobokalonov; Lisa Mattei; Huanjia Zhang; Pieter Van den Abbeele
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-25       Impact factor: 4.813

Review 5.  The intestinal microbiome in type 1 diabetes.

Authors:  J L Dunne; E W Triplett; D Gevers; R Xavier; R Insel; J Danska; M A Atkinson
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  Considerations for best practices in studies of fiber or other dietary components and the intestinal microbiome.

Authors:  David M Klurfeld; Cindy D Davis; Robert W Karp; Emma Allen-Vercoe; Eugene B Chang; Benoit Chassaing; George C Fahey; Bruce R Hamaker; Hannah D Holscher; Johanna W Lampe; Andre Marette; Eric Martens; Stephen J O'Keefe; Devin J Rose; Maria Saarela; Barbara O Schneeman; Joanne L Slavin; Justin L Sonnenburg; Kelly S Swanson; Gary D Wu; Christopher J Lynch
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-21       Impact factor: 4.310

Review 7.  Microbiome therapeutics - Advances and challenges.

Authors:  Mark Mimee; Robert J Citorik; Timothy K Lu
Journal:  Adv Drug Deliv Rev       Date:  2016-05-05       Impact factor: 15.470

8.  Effect of flow and peristaltic mixing on bacterial growth in a gut-like channel.

Authors:  Jonas Cremer; Igor Segota; Chih-Yu Yang; Markus Arnoldini; John T Sauls; Zhongge Zhang; Edgar Gutierrez; Alex Groisman; Terence Hwa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-28       Impact factor: 11.205

9.  Evaluating the Impact of Four Major Nutrients on Gut Microbial Metabolism by a Targeted Metabolomics Approach.

Authors:  Kundi Yang; Mengyang Xu; Jiangjiang Zhu
Journal:  J Proteome Res       Date:  2020-04-23       Impact factor: 4.466

Review 10.  Mapping the inner workings of the microbiome: genomic- and metagenomic-based study of metabolism and metabolic interactions in the human microbiome.

Authors:  Ohad Manor; Roie Levy; Elhanan Borenstein
Journal:  Cell Metab       Date:  2014-08-28       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.